Full Coverage

Bavarian Nordic sells priority review voucher for $160 million

Top news

The Pharma Letter

Bavarian Nordic banks big amount for priority review voucher

2 days ago

Bavarian Nordic's $160M FDA speedy review voucher sale shows prices keep rising amid concerns over key program

4 days ago

By Angus Liu

Bavarian Nordic’s PRV goes for $160M; Biomea to advance GLP-1 into trials

4 days ago

Pharmaceutical Technology

Bavarian Nordic nets $160m from priority review voucher sale

4 days ago

By Robert Barrie

Bavarian Nordic (BVNKF) Sells Priority Review Voucher for $160 M

4 days ago

All coverage

Bavarian Nordic Announces Sale of Priority Review Voucher for USD 160 Million

4 days ago

Bavarian Nordic scores top price for priority voucher – was not pressured into a quick sale by shareholders

4 days ago

Bavarian Nordic to Sell US Priority Review Voucher for $160 Million

4 days ago

Bavarian Nordic sells its Priority Review Voucher for $160M

4 days ago

By Manshi Soneji Mamtora, CFA

Bavarian Nordic's USD 160m voucher sale indicates rising value

3 days ago

Bavarian Nordic sells priority review voucher to US healthcare system USD 160m

4 days ago

Search

Clear search

Close search

Google apps

Main menu